The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Completed

Conditions studied: Breast Cancer

In brief

Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.

Key facts

Study ID

NCT01341171

Run by

University of Vermont

People needed

30

Starts

2009-08-01

Expected to finish

2018-10-01

Last updated by the study team

2020-09-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• women routinely taking tamoxifen or aromatase inhibitor therapy as prescribed by their oncologist

You may not qualify if…

• Use of heparin, warfarin

Where it is running

• University of Vermont — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.